Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
HUNYVERS Aktie jetzt für 0€ handeln |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
GILEAD SCIENCES | 95,46 | -1,67 % | Dividendenbekanntmachungen (15.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2954 EUR ALLEGION PLC IE00BFRT3W74 0,51 USD 0,4345 EUR ALTRIA GROUP INC US02209S1033 1... ► Artikel lesen | |
CANOPY GROWTH | 1,124 | -4,26 % | Canopy Growth Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
MERCK & CO | 68,20 | -1,73 % | Merck & Co.'s KEYTRUDA QLEX Approved by the FDA | ||
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
JAGUAR HEALTH | 2,030 | 0,00 % | Jaguar Health, Inc.: Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts | Click here to register SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / September 5, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO,... ► Artikel lesen | |
MADRIGAL PHARMACEUTICALS | 376,00 | +0,43 % | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) | CONSHOHOCKEN, Pa., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated... ► Artikel lesen | |
IQVIA | 158,60 | -0,50 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 05.09.2025 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
INTERCEPT PHARMACEUTICALS | - | - | Long Regulatory Saga for Intercept Pharma Liver Drug Ends a Decade After Speedy FDA Approval | ||
AZENTA | 26,800 | +1,52 % | Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance | BURLINGTON, Mass., Aug. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2025.
... ► Artikel lesen | |
PROTHENA | 7,100 | +2,90 % | Prothena Corporation plc: Prothena to Participate in the Cantor Fitzgerald Global Healthcare Conference | Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced... ► Artikel lesen | |
ALMIRALL | 11,560 | +0,70 % | Almirall, S.A.: Almirall Presents Long-Term Results from First Real-World Dermatology Study Using WHO-5 Well-Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 2025 | Results of the POSITIVE study assessing the treatment with tildrakizumab showed sustained improvements in skin clearance, psychological well-being, and improved partner quality of life in adults... ► Artikel lesen | |
FUJI PHARMA | 8,950 | +1,70 % | Dividendenbekanntmachungen (28.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20... ► Artikel lesen | |
FINANCIERE DE TUBIZE | 166,00 | +1,10 % | Financière de Tubize SA: Financière de Tubize - Convening of the extraordinary general meeting of shareholders of Sep. 24, 2025 | Convening of the Extraordinary General Meeting of shareholders of 24 September 2025
The shareholders are invited to attend the extraordinary general meeting, which will take place on 24 September... ► Artikel lesen | |
BAYER | 27,460 | -0,15 % | Bayer treibt Parkinson-Forschung voran: Phase-III-Studie mit Bemdaneprocel angelaufen | Die Bayer AG hat wichtige Schritte bei der Entwicklung neuer Therapien gegen Parkinson gemeldet. In die Phase-III-Studie exPDite-2 mit dem Zelltherapiekandidaten Bemdaneprocel wurde ein erster Patient... ► Artikel lesen | |
MERCK KGAA | 109,25 | +0,92 % | From Design to Impact: MilliporeSigma's First Climate-Neutral Manufacturing Facility | NORTHAMPTON, MA / ACCESS Newswire / September 22, 2025 / MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announces... ► Artikel lesen |